Home Drones General Atomics and U.S. Air Force Conduct Flight Test of APKWS on MQ-9A Reaper
European defence news, Aerospace and defence news, Defence technology news, European military news, Defence industry Europe, European defence companies, Defence procurement Europe, Military drone news, European aerospace companies, Military aviation news, NATO defence news, Space defence news Europe, Cyber defence news, Counter UAS news, European security and defence, Defence contracts Europe, European defence market, Unmanned systems Europe, defence magazines in Europe, drone magazines in Europe,

General Atomics and U.S. Air Force Conduct Flight Test of APKWS on MQ-9A Reaper

by EDI Editorial Staff

General Atomics Aeronautical Systems, Inc. (GA-ASI), in collaboration with the U.S. Air Force (USAF), has successfully conducted flight tests of an Advanced Precision Kill Weapon System (APKWS) using a USAF MQ-9A Reaper Remotely Piloted Aircraft. The MQ-9A is produced by GA-ASI. The testing took place recently at the Nevada Test and Training Range (NTTR).

The demonstration featured multiple types and variations of shot profiles, including engagements against aerial targets. All shots were executed flawlessly by the MQ-9A crews using laser-guided rockets and a specialized launcher. This effort supported real-time technological adaptation requirements, moving rapidly from planning to integration and flight test. It also brought together multiple Department of War stakeholders and their industry partners.

David R. Alexander, President of GA-ASI, stated:
“We recognize the value that a system like APKWS brings to the MQ-9 aircraft as a tool to counter one-way attack drones. APKWS can increase the number of weapons the MQ-9A is able to carry, as well as enable new lower-cost weapons. More than anything, this integration effort underscores how government and industry can collaborate to rapidly test and make new capabilities available to warfighters.”

Related Posts

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More